rs3729587
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004628.5(XPC):c.621+44C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.287 in 1,501,174 control chromosomes in the GnomAD database, including 65,015 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.34   (  9512   hom.,  cov: 32) 
 Exomes 𝑓:  0.28   (  55503   hom.  ) 
Consequence
 XPC
NM_004628.5 intron
NM_004628.5 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.387  
Publications
10 publications found 
Genes affected
 XPC  (HGNC:12816):  (XPC complex subunit, DNA damage recognition and repair factor) The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017] 
XPC Gene-Disease associations (from GenCC):
- xeroderma pigmentosum group CInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Myriad Women’s Health, Genomics England PanelApp
 - xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98). 
BP6
Variant 3-14167125-G-C is Benign according to our data. Variant chr3-14167125-G-C is described in ClinVar as Benign. ClinVar VariationId is 259472.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.494  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.338  AC: 51370AN: 151922Hom.:  9495  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
51370
AN: 
151922
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.306  AC: 54818AN: 179048 AF XY:  0.296   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
54818
AN: 
179048
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.282  AC: 380053AN: 1349134Hom.:  55503  Cov.: 21 AF XY:  0.280  AC XY: 186011AN XY: 663176 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
380053
AN: 
1349134
Hom.: 
Cov.: 
21
 AF XY: 
AC XY: 
186011
AN XY: 
663176
show subpopulations 
African (AFR) 
 AF: 
AC: 
15273
AN: 
29638
American (AMR) 
 AF: 
AC: 
14590
AN: 
33300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
5075
AN: 
21892
East Asian (EAS) 
 AF: 
AC: 
9127
AN: 
36190
South Asian (SAS) 
 AF: 
AC: 
22251
AN: 
71004
European-Finnish (FIN) 
 AF: 
AC: 
12125
AN: 
50722
Middle Eastern (MID) 
 AF: 
AC: 
1195
AN: 
5358
European-Non Finnish (NFE) 
 AF: 
AC: 
284590
AN: 
1045360
Other (OTH) 
 AF: 
AC: 
15827
AN: 
55670
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 13194 
 26388 
 39582 
 52776 
 65970 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 10070 
 20140 
 30210 
 40280 
 50350 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.338  AC: 51445AN: 152040Hom.:  9512  Cov.: 32 AF XY:  0.339  AC XY: 25158AN XY: 74296 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
51445
AN: 
152040
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
25158
AN XY: 
74296
show subpopulations 
African (AFR) 
 AF: 
AC: 
20702
AN: 
41458
American (AMR) 
 AF: 
AC: 
5676
AN: 
15278
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
807
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
1332
AN: 
5164
South Asian (SAS) 
 AF: 
AC: 
1584
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
2415
AN: 
10568
Middle Eastern (MID) 
 AF: 
AC: 
76
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
18007
AN: 
67962
Other (OTH) 
 AF: 
AC: 
674
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1692 
 3383 
 5075 
 6766 
 8458 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 494 
 988 
 1482 
 1976 
 2470 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1186
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:6 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Xeroderma pigmentosum, group C    Benign:2 
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Xeroderma pigmentosum group A    Benign:1 
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.